# Rumen-Protected Glucose Supplementation Enhances Yak Calf Growth Through Gut Microbiota–Metabolic Interactions

**Authors:** Jingyun Chen, Lan Ma, Zongyuan Zhang, Fuzhen An, Xinyue Li, Biao Li, Tianwu An, Li Wang

PMC · DOI: 10.3390/ani16040683 · Animals : an Open Access Journal from MDPI · 2026-02-21

## TL;DR

Adding rumen-protected glucose to yak mothers' diets improves calf growth by enhancing milk quality and gut microbiota.

## Contribution

This study reveals transgenerational benefits of low-dose rumen-protected glucose supplementation in yaks through microbiota-metabolite interactions.

## Key findings

- Low-dose RPG supplementation increased milk nutrients and calf weight gain by 21.74%.
- Calves showed improved antioxidant and immune functions with higher SOD, CAT, and lower IL-6, TNF-α.
- RPG enriched beneficial gut bacteria like Akkermansia muciniphila and upregulated key metabolites.

## Abstract

This study investigated the effects of rumen-protected glucose (RPG) supplementation on calf health in periparturient yaks. The findings revealed that daily supplementation with 150 g of low-dose RPG (L-RPG) significantly increased protein, fat, lactose, and total energy content in dam milk, while concurrently promoting calf body weight gain and activating growth axis-related hormones. Furthermore, calves in the L-RPG group exhibited enhanced antioxidant capacity and improved immunomodulatory function. Multi-omics analysis further revealed that L-RPG could optimize the hindgut microbiota structure of calves, enrich beneficial bacteria such as Akkermansia muciniphila, and upregulate serum levels of metabolites associated with microbial metabolism. In summary, maternal supplementation with low-dose RPG synergistically promotes offspring growth and development by improving milk quality, modulating calf gut microbiota and host metabolism, thereby providing theoretical basis and practical guidance for integrated dam–calf health management in yak farming.

Alleviating negative energy balance in perinatal yaks is a critical challenge for safeguarding the health of both dams and calves and achieving sustainable development of yak husbandry. While RPG supplementation represents an effective nutritional strategy, its transgenerational benefits, particularly the long-term effects on offspring calf development through maternal intervention, remain largely unexplored. In the present study, low-dose RPG (150 g d−1, L-RPG, n = 6) markedly improved milk composition, elevating protein, fat, lactose, and gross energy contents (p < 0.05), and enhance calf weight gain (21.74%) with activation of the somatotropic axis (increased GH, IGF-1, etc.). Calves in this group also exhibited enhanced antioxidant capacity (higher SOD, CAT, and T-AOC) and improved immune regulation (lower IL-6, TNF-α). Multi-omics analyses revealed that L-RPG enriched beneficial taxa such as Solbacillus, Citricoccus, and Akkermansia muciniphila, optimized the hindgut microbiome, and upregulated serum metabolites including di-O-methylfraxetin and phenylalanyl-histidine. Integrated microbiota–metabolite profiling demonstrated significant cross-talk between the altered bacteria and metabolites. Collectively, supplementing dams with 150 g d−1 RPG improves milk quality, modulates the calf gut microbiota, and reshapes host metabolism, thereby synergistically promoting offspring growth. Our findings provide a comprehensive “maternal nutrition–microbiota–metabolism” framework for understanding RPG’s mode of action and furnish both theoretical insights and practical guidance for dam–calf health management in yak production systems.

## Linked entities

- **Proteins:** GH1 (growth hormone 1), IGF1 (insulin like growth factor 1), SOD1 (superoxide dismutase 1), CAT (catalase), IL6 (interleukin 6), TNF (tumor necrosis factor)
- **Chemicals:** di-O-methylfraxetin (PubChem CID 3083928), phenylalanyl-histidine (PubChem CID 152198)
- **Species:** Bos grunniens (taxon 30521), Akkermansia muciniphila (taxon 239935), Citricoccus (taxon 169133)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 280717], IGFBP2 (insulin like growth factor binding protein 2) [NCBI Gene 282260], INS (insulin) [NCBI Gene 280829], IL6 (interleukin 6) [NCBI Gene 280826], IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 282261] {aka IGFBP-3}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 281333] {aka mucin}, IGF1 (insulin like growth factor 1) [NCBI Gene 281239] {aka IGF-1, IGF-I}, GHRH (growth hormone releasing hormone) [NCBI Gene 281191], CAT (catalase) [NCBI Gene 531682], VIP (vasoactive intestinal peptide) [NCBI Gene 280956], SST (somatostatin) [NCBI Gene 280932], LOC517016 (interleukin 6 (interferon, beta 2)) [NCBI Gene 517016] {aka IF1DA6}, GGH (gamma-glutamyl hydrolase) [NCBI Gene 525303], TNF (tumor necrosis factor) [NCBI Gene 280943] {aka TNF-a, TNF-alpha, TNFa}, IL10 (interleukin 10) [NCBI Gene 281246] {aka IF2A}
- **Diseases:** injury to (MESH:D014947), inflammatory (MESH:D007249), weight loss (MESH:D015431), hypoxic (MESH:D002534), fatty liver (MESH:D005234), weight gain (MESH:D015430), ketosis (MESH:D007662), Body-Weight Loss (MESH:D001835), metabolic disorders (MESH:D008659), RPG (MESH:D018149)
- **Chemicals:** JM (MESH:D015570), carnosic acid (MESH:C018381), Unsaturated fatty acids (MESH:D005231), phosphate (MESH:D010710), phosphorus (MESH:D010758), linoleic acid (MESH:D019787), methanol (MESH:D000432), BHBA (MESH:D020155), 12:1+1O (-), fatty acids (MESH:D005227), arginine (MESH:D001120), malondialdehyde (MESH:D008315), TG (MESH:D014280), chitin (MESH:D002686), CTAB (MESH:D000077286), Amino acids (MESH:D000596), MDA (MESH:D015104), nitrogen (MESH:D009584), oxalate (MESH:D010070), lactose (MESH:D007785), canrenoate (MESH:D002191), phenylalanyl-histidine (MESH:C022144), purine (MESH:C030985), nucleosides (MESH:D009705), agarose (MESH:D012685), lipid (MESH:D008055), alpha-linolenic acid (MESH:D017962), water (MESH:D014867), Zedoarol (MESH:C000601582), 5'-deoxy-5-fluorocytidine (MESH:C418208), Fa (MESH:D005492), GLU (MESH:D005947), ketone bodies (MESH:D007657), benzamide (MESH:C037689), cholesterol (MESH:D002784), guanosine (MESH:D006151), tryptophan (MESH:D014364), SDS (MESH:D012967), cellulose (MESH:D002482), H (MESH:D006859), 4-hydroxy-6-methyl-2-pyrone (MESH:C525072), isoguanosine (MESH:C008184)
- **Species:** Oxalobacter formigenes (species) [taxon 847], Escherichia coli (E. coli, species) [taxon 562], Subdoligranulum (genus) [taxon 292632], Akkermansia muciniphila (species) [taxon 239935], Faecalibacterium (genus) [taxon 216851], Phocea [taxon 1926663], Homo sapiens (human, species) [taxon 9606], Bacteroides fluxus (species) [taxon 626930], Sanguibacter keddieii DSM 10542 (strain) [taxon 446469], Citricoccus alkalitolerans (species) [taxon 246603], Fusobacterium (genus) [taxon 848], Bacteroides fragilis (species) [taxon 817], Enterocloster aldenensis (species) [taxon 358742], Citricoccus (genus) [taxon 169133], Bos taurus (bovine, species) [taxon 9913], Butyricicoccus (genus) [taxon 580596], Ovis aries (domestic sheep, species) [taxon 9940], Shigella (genus) [taxon 620], Bos grunniens (domestic yak, species) [taxon 30521], Arthrobacter citreus (species) [taxon 1670], Limosilactobacillus reuteri (species) [taxon 1598], Ovis canadensis (bighorn sheep, species) [taxon 37174]
- **Mutations:** phenylalanine/tyrosine
- **Cell lines:** L-RPG — Bos taurus (Bovine), Transformed cell line (CVCL_B5LA)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937241/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937241/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937241/full.md

---
Source: https://tomesphere.com/paper/PMC12937241